MedPath

Brain Imaging: Cocaine Effects & Medication Development - 5

Phase 4
Withdrawn
Conditions
Cocaine-Related Disorders
Registration Number
NCT00000270
Lead Sponsor
New York State Psychiatric Institute
Brief Summary

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relative change in rCBF at 5, 19, & 33 minutes (O15)
Absolute change in rCBF at 5 & 15 minutes (Xe)
Correlated with a) subjective effects, b) venous blood level of coca, c) autonomic variables
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York State Psychiatric Institute

πŸ‡ΊπŸ‡Έ

New York, New York, United States

New York State Psychiatric Institute
πŸ‡ΊπŸ‡ΈNew York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.